United States · Bill · HR
H.R. 2883 (117th)
Stop Stalling Access to Affordable Medications
Introduced
28 April 2021
Last action
—
Status
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
Stop Stalling Access to Affordable Medications This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 28 April 2021
Introduced in House (PDF)
Introduced in House · EN · 28 April 2021
Introduced in House
summary · EN · 28 April 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/2883
- Open data entity: https://api.congress.gov/v3/bill/117/hr/2883